ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Young Investigators Hold Their Own

September 28, 1979

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002